Cancer Genetics Inc.
NASDAQ: CGIX | Healthcare / Medical Laboratories & Research / USA |
1.10 | -0.10 | -8.33% | Vol 1 576 162 | 1Y Perf -72.91% |
BID | 1.06 | | ASK | 1.11 | |
Open | 1.21 | | Previous Close | 1.20 | |
Pre-Market | - | | After-Trading | 1.10 |
| - -% | | | - -% |
Today's Price Range
1.051.28
| | | |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Last QuotesName / Ticker | Price | Chg. | Chg.% |
---|
CGIX | 1.10 | -0.1000 | -8.33 |
AAPL | 165.72 | -7.0800 | -4.10 |
GOOG | 1 072.96 | -14.7400 | -1.36 |
MSFT | 95.00 | -1.1100 | -1.15 |
XOM | 79.00 | -0.4200 | -0.53 |
WFC | 52.56 | 1.0200 | 1.98 |
JNJ | 126.66 | -0.8900 | -0.70 |
FB | 166.28 | -1.8200 | -1.08 |
GE | 14.54 | 0.5500 | 3.93 |
JPM | 111.47 | -0.2500 | -0.22 |
Ticker | Price | Chg.% | 52 Week High |
---|
RF | 18.89 | 4.08 | 20.21 |
XRX | 31.54 | 3.99 | 37.42 |
GE | 14.54 | 3.93 | 30.38 |
HRB | 27.10 | 2.92 | 31.80 |
ETFC | 60.48 | 2.80 | 61.80 |
SCHW | 54.99 | 2.44 | 58.11 |
SIG | 38.65 | 2.17 | 77.94 |
UAL | 71.75 | 2.16 | 83.04 |
WFC | 52.56 | 1.98 | 66.31 |
RE | 246.99 | 1.91 | 277.17 |
M | 29.96 | 1.87 | 31.04 |
CTL | 17.61 | 1.67 | 27.61 |
HON | 150.57 | 1.65 | 165.13 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|
Quick Ratio | 1.00 | | | |
Current Ratio | 1.20 | | | |
Long Term Debt to Total Capital | 0.02 | | | |
Total Debt to Equity | 0.41 | | | |
Interest Coverage | -9.80 | | | |
Leverage Ratio | 2.10 | | | |
Profitability | Value | Industry | S&P 500 | US Markets |
---|
Gross Margin | 40.70 | | | |
EBIT Margin | -54.90 | | | |
EBITDA Margin | -47.00 | | | |
Pre-tax Profit Margin | -127.80 | | | |
Profit Margin | -51.00 | | | |
Valuation | Value | Industry | S&P 500 | US Markets |
---|
PE Ratio | - | | | |
PB Ratio | 1.01 | | | |
PS Ratios | 1.21 | | | |
Price to Cash Flow | - | | | |
Price to Free Cash Flow | -2.00 | | | |
Cash Flow Per Share | -0.66 | | | |
Price to Tangible Book | 6.26 | | | |
Book Value per Share | 0.96 | | | |
Enterprise Value (in ths.) | 28 394 | | | |
Management Effectiveness | Value | Industry | S&P 500 | US Markets |
---|
Return on Equity (5Y Avg) | -61.32 | | | |
ROE last 12 Months | -79.71 | | | |
Return on Assets (5Y Avg) | -36.29 | | | |
ROA last 12 Months | -44.12 | | | |
Return on Capital (5Y Avg) | -46.14 | | | |
ROC last 12 Months | -41.28 | | | |
Return on invested Capital Q | -17.47 | | | |
Return on invested Capital Y | -55.43 | | | |
Assets Turnover | 0.20 | | | |
Receivables Turnover | 0.70 | | | |
Revenue | Value | Industry | S&P 500 | US Markets |
---|
Revenue LTM (in ths.) | 22 155 | | | |
Revenue per Share | 0.80 | | | |
Revenue Growth 3 Years | 32.22 | | | |
Revenue Growth 5 Years | 48.89 | | | |
Dividends | Value | Industry | S&P 500 | US Markets |
---|
Dividend Yield | - | | | |
Dividend Rate | - | | | |
Dividend Growth 3 Years | - | | | |
Dividend Growth 5 Years | - | | | |
Earnings History | Estimate | Reported | Surprise % |
---|
Q04 2017 | - | -0.35 | - |
Q03 2017 | -0.13 | -0.16 | -23.08 |
Q02 2017 | -0.16 | -0.16 | 0.00 |
Q01 2017 | -0.18 | -0.11 | 38.89 |
Q04 2016 | -0.22 | -0.15 | 31.82 |
Q03 2016 | -0.28 | -0.23 | 17.86 |
Q02 2016 | -0.33 | -0.28 | 15.15 |
Q01 2016 | -0.43 | -0.39 | 9.30 |
Earnings Per End | Estimate | Revision % | Trend |
---|
3/2018 QR | -0.08 | 0.00 | - |
6/2018 QR | -0.04 | 0.00 | - |
12/2018 FY | -0.23 | -21.05 | Negative |
12/2018 FY | -0.17 | 10.53 | Positive |
Next Report Date | 10th May 2018 |
Estimated EPS Next Report | -0.08 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|
Volume | 1 576 162 |
Shares Outstanding (in ths.) | 27 750 |
Trades Count | 1 672 |
Dollar Volume | 1 789 564 |
Avg. Volume | 611 980 |
Avg. Weekly Volume | 7 016 978 |
Avg. Monthly Volume | 1 959 359 |
Avg. Quarterly Volume | 700 587 |
Bearish or Bullish?Week | Month | Three Months | Six Months |
---|

Bearish Bullish | 
Bearish Bullish | 
Bearish Bullish | 
Bearish Bullish |
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|
Strong Buy | 2 (50.00 %) | 4 (100.00 %) | 4 (100.00 %) |
Moderate Buy | 0 (0.00 %) | 0 (0.00 %) | 0 (0.00 %) |
Hold | 2 (50.00 %) | 0 (0.00 %) | 0 (0.00 %) |
Moderate Sell | 0 (0.00 %) | 0 (0.00 %) | 0 (0.00 %) |
Strong Sell | 0 (0.00 %) | 0 (0.00 %) | 0 (0.00 %) |
Rating | Moderate Buy2.00 | Strong Buy1.00 | Strong Buy1.00 |
There are no comments yet.